Redesign Health Expands Investment Platform with Growth Equity Practice

The practice backs healthcare companies from Series A through pre-IPO, complementing the company's seed and venture buyout strategies

NEW YORK, Nov. 13, 2026 /PRNewswire/ -- Redesign Health today announced the formal launch of its Growth Equity practice, expanding the firm's ability to back healthcare founders and management teams. The practice will make minority investments from Series A through pre-IPO, with a focus on healthcare IT, AI-enabled services, and clinical AI.

Redesign Health has invested in healthcare companies since its founding in 2018 and has already made opportunistic growth-stage investments, including Hippocratic AI. The new practice gives that activity a dedicated team and mandate.

"Investing has always been central to Redesign Health. Growth Equity expands our ability to back exceptional companies at pivotal points in their development," said Brett Shaheen, CEO of Redesign Health. "Across our investment strategies, we share a common purpose: supporting founders whose businesses can improve how healthcare works."

Growth Equity focuses on businesses with existing customers, revenue, and product-market fit. It complements the company's seed strategy, which backs founders at the earliest stages, and its venture buyout strategy, which takes control positions in established businesses and applies AI to improve their operations.

The practice draws on Redesign Health's investment expertise, technology capabilities, and relationships across health systems, health plans, and providers. The firm's October merger with ARC Global and agreement to acquire AVIA further expand those relationships, connecting the company to more than 100 health systems worldwide.

Richie Chaikof has joined Redesign Health as Managing Director, Growth Equity, to lead the practice within the firm's broader investing team. He brings healthcare investing experience from Optum Ventures and Bain Capital Ventures. The team also includes Akhilesh Pathipati, a physician and former partner at MVM, where he invested in high-growth healthcare companies.

"AI can now address challenges in healthcare where earlier generations of technology fell short, at a time when the system urgently needs new approaches," said Chaikof. "The most consequential companies will use those capabilities to advance clinical excellence, broaden access for patients, and reduce the total cost of care. I look forward to investing in and supporting the next generation of breakout healthcare companies."

"We aim to be a competitive advantage for the founders we back," said Neil Patel, Head of Investing at Redesign Health. "Our investing team brings the expertise and relationships of the broader Redesign platform to help founders reach customers, find the right partners, and work through the decisions that will define their companies."

Founders and co-investors can reach the Growth Equity team at [email protected].

About Redesign Health

Redesign Health is a global technology company powering the future of healthcare. Our transformation business embeds technologists and product leaders inside the world's leading health institutions, working alongside clinicians and operators to build solutions from within. Our investment business backs exceptional founders from inception through growth, and partners with proven management teams through control investments to rewire core products and workflows with AI. We leverage a proprietary AI operating system to help our partners identify opportunities, develop and deploy solutions, and scale innovations that improve care for patients worldwide. Redesign Health is based in New York and has offices in Bengaluru, Boston, Los Angeles, Riyadh, and Tel Aviv. For more information, visit www.redesignhealth.com. 

MEDIA CONTACTS:
Redesign Health
[email protected]

SOURCE Redesign Health